SAN DIEGO, CA / ACCESSWIRE / June 2, 2016 / TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company"), a company that develops and markets point of care ophthalmic in-vitro diagnostics, today announced that its Chief Executive Officer, Seph Jensen, will present a Company overview and business update at the 6th Annual LD Micro Invitational on Thursday, June 9, 2016 at 11:30 am PT/2:30 pm ET. The conference will be held at the Luxe Sunset Bel Air Hotel in Los Angeles, CA.
There will be a live webcast of the presentation which will be accessible on the investors' page of the Company's website under webcasts at www.tearlab.com/investors/webcasts.htm.
TearLab's management will host one-on-one meetings at the conference. To schedule a meeting with the Company, please contact David Burke at dburke@theruthgroup.com or 646-536-7009.
About TearLab Corporation
TearLab Corporation (www.tearlab.com) develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The TearLab Osmolarity® Test, for diagnosing Dry Eye Disease, is the first assay developed for the award-winning TearLab Osmolarity System. TearLab Corporation's common shares trade on the NASDAQ Capital Market under the symbol 'TEAR' and on the Toronto Stock Exchange under the symbol 'TLB'.
Forward-Looking Statements
In order to provide TearLab's investors with an understanding of our current intentions and future prospects, this release may contain statements that are forward-looking. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will," "intends," "potential," "possible" and similar expressions are intended to identify forward-looking statements. These forward-looking statements include our expectations regarding our future fundraising activities.
Forward-looking statements involve risks and uncertainties related to our business and the general economic environment, many beyond our control. These risks, uncertainties and other factors could cause our actual results to differ materially from those projected in forward-looking statements, including market risk and the risks we identify in reports filed with the Securities and Exchange Commission.
Although we believe that the forward-looking statements contained herein are reasonable, we can give no assurance that our expectations are correct. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. For a detailed description of our risks and uncertainties, you are encouraged to review the official corporate documents filed with the Securities and Exchange Commission. TearLab does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof.
About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).
In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.
For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.
INVESTOR CONTACT:
The Ruth Group
David Burke
Tel: 646-536-7009
dburke@theruthgroup.com
SOURCE: TearLab Corporation via LD Micro
ReleaseID: 440703
